Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSE Regulatory News (SSE)

Share Price Information for SSE (SSE)

Share Price is delayed by 15 minutes
Get Live Data
2,358.00    -25.00 (-1.05%)
Bid:
2,363.00
Ask:
2,364.00
Spread: 1.00 (0.042%)
Market Cap: £28.44b
SSE Live PriceLast checked at - London Stock Exchange

Intraday SSE Share Chart

Scrip Alternative

29 Aug 2024 12:00

RNS Number : 1788C
SSE PLC
29 August 2024
 

SSE PLC

FINAL DIVIDEND FOR THE YEAR ENDED 31 MARCH 2024

SCRIP ALTERNATIVE

SSE plc was notified on 28 August 2024 that a total of 24,277 shareholders have elected to receive the final dividend for the year ended 31 March 2024 of 40 pence per ordinary share in respect of 563,868,396 ordinary shares in the form of Scrip dividend. This will result in a reduction in final dividend cash funding of £225,547,358.

A total of 12,203,570 new ordinary shares, fully paid, will be issued on 19 September 2024, representing an increase of 1.12% on the issued share capital (excluding treasury shares) on the dividend record date of 26 July 2024. The relevant Scrip Reference Share Price was 1,848 pence per ordinary share.

The Group's dividend plan to 2026/27 includes the intention to cap the scrip dividend alternative at 25% of investor uptake, through a share buy-back where required. Following notification of the final dividend elections, the Group can confirm that overall scrip dividend take-up for the financial year ended 31 March 2024 was 35.7%. In accordance with the authority granted by shareholders at SSE's Annual General Meeting on 18 July 2024 and Chapter 12 of the Listing Rules, the Group therefore intends to initiate a share buy-back in the period following the final dividend payment for the year ended 31 March 2024. The number of ordinary shares to be purchased will not exceed 3,806,487 ordinary shares, and the maximum pecuniary amount allocated to the Scrip buy-back is £75,000,000. SSE plc intends to complete this process by 31 March 2025.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVFLFVITVIAFIS
Date   Source Headline
9th Oct 20249:03 amRNSDirector/PDMR Shareholding
9th Oct 20247:00 amRNSTransaction in Own Shares
8th Oct 20247:00 amRNSTransaction in Own Shares
7th Oct 20247:00 amRNSTransaction in Own Shares
4th Oct 20247:00 amRNSTransaction in Own Shares
3rd Oct 20247:00 amRNSTransaction in Own Shares
3rd Oct 20247:00 amRNSNotification of Closed Period
2nd Oct 202410:47 amRNSDirector/PDMR Shareholding
2nd Oct 20247:00 amRNSTransaction in Own Shares
1st Oct 20243:46 pmRNSTotal Voting Rights
1st Oct 20247:00 amRNSTransaction in Own Shares
30th Sep 202410:03 amRNSNon-Discretionary Share Buyback Programme
25th Sep 20244:38 pmRNSDirector/PDMR Shareholding
23rd Sep 20243:30 pmRNSDirector/PDMR Shareholding
17th Sep 20248:00 amRNSAdditional Listing
10th Sep 20244:44 pmRNSDirector/PDMR Shareholding
3rd Sep 20248:25 amRNSUK Contracts for Difference Allocation Round 6
2nd Sep 20247:00 amRNSTotal Voting Rights
30th Aug 202410:00 amRNSBlock Listing Six Monthly Return
30th Aug 20248:30 amRNSDirector/PDMR Shareholding
29th Aug 202412:00 pmRNSScrip Alternative
28th Aug 20245:12 pmRNSIssuance of Green Bond
9th Aug 202410:57 amRNSDirector/PDMR Shareholding
1st Aug 202411:32 amRNSScrip Dividend Scheme
1st Aug 20247:00 amRNSTotal Voting Rights
30th Jul 20243:41 pmRNSHolding(s) in Company
22nd Jul 20249:06 amRNSHolding(s) in Company
18th Jul 20244:16 pmRNSResult of AGM
18th Jul 20247:31 amRNSOfgem RIIO-3 Sector Specific Methodology Decision
18th Jul 20247:00 amRNSQ1 Trading Statement
10th Jul 20243:36 pmRNSDirector/PDMR Shareholding
10th Jul 20249:28 amRNSDirector/PDMR Shareholding
9th Jul 20243:26 pmRNSDirector/PDMR Shareholding
9th Jul 20247:00 amRNSSSE & partners advance 2GW offshore windfarm in NL
1st Jul 20249:25 amRNSTotal Voting Rights
14th Jun 20241:00 pmRNSAnnual Financial Report
14th Jun 202411:22 amRNSDirector/PDMR Shareholding
10th Jun 20243:40 pmRNSDirector/PDMR Shareholding
3rd Jun 20244:15 pmRNSDirector/PDMR Shareholding
3rd Jun 20247:00 amRNSTotal Voting Rights
23rd May 20249:23 amRNSDividend Timetable
23rd May 20247:01 amRNSDirector Declaration
22nd May 20247:00 amRNSPreliminary Results for the year ended 31 March 24
8th May 202412:05 pmRNSDirector/PDMR Shareholding
1st May 20247:00 amRNSTotal Voting Rights
10th Apr 20244:22 pmRNSDirector/PDMR Shareholding
9th Apr 20242:31 pmRNSDirector/PDMR Shareholding
2nd Apr 20249:37 amRNSTotal Voting Rights
27th Mar 20247:00 amRNSNotification of Closed Period
19th Mar 202411:00 amRNSSSEN Transmission welcomes ‘Beyond 2030’ plan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.